<DOC>
	<DOCNO>NCT03070275</DOCNO>
	<brief_summary>Systemically healthy volunteer active periodontal disease recruit referral Dept . Preventive Dentistry , Periodontology Biology Implants , Aristotle Univ Thessaloniki implant therapy . After sign consent form , participant randomize two treatment group . Group-A ( NA=10 ) receive crestal placement implant follow two-stage protocol combination biocomplex comprise autologous alveolar bone marrow mesenchymal stem cell free animal derive reagent , produce clean room facility seed collagen scaffold enrich autologous fibrin glue . In Group-B ( NB=10 ) implant place alveolar crest follow two-stage protocol manufacturer 's guideline . Intra-surgical clinical radiographic assessment perform time implant placement ( T0 ) two-stage surgery ( T1 ) . Changes mucosa thickness , width keratinize tissue , marginal bone bone thickness surgical site determine T0-T1 . Groups divide two subgroup base mucosal thickness surgical site T0 [ thin mucosa ( ≤2.5mm ) Groups-AI/-BI ; thick mucosa ( &gt; 2.5mm ) Groups-AII/-BII ] . A linear mixed model repeat measure use data analysis determine change dimension peri-implant soft hard tissue , around two stage-implants place either conventionally , combination biocomplex .</brief_summary>
	<brief_title>Dental Implant Placement Adjunction With Autologous Alveolar Bone-Marrow Derived Mesenchymal Stem Cells ( aBM-MSCs )</brief_title>
	<detailed_description>Aims &amp; Objectives : The present study describes novel method preserve crestal bone two-stage dental implant use autologous aBMMSCs , free animal derive reagent , produce clean room facility enrich autologous fibrin glue seed commercially available collagen scaffold ( collagen fleece ) stabilize implant platform upon surgical implant placement . Primary objective : This study aim assess efficacy novel method base histotechnology crestal bone preservation two-stage dental implant , compare conventional surgical implant placement follow manufacturer 's guideline adjunctive use grafting material . Secondary , change peri-implant soft tissue also determine implant placement exposure compare experimental conventional surgical treatment approach . Study design : Biopsies derive alveolar bone marrow alveolar bone local anaesthesia patient belong Experimental Group ( Group-A ) . Briefly , thorough oral rinse chlorhexidine 0.12 % 1min , osteotomy use trephine drill perform alveolar bone intraoral edentulous site implant site 2x8 mm 3cc approximately osseous core harvest . The area biopsy copiously irrigated saline solution flap suture achieve primary closure donor site . The bone sample immediately place sterile tube transport Biohellenika , Thessaloniki , Greece ( http : //www.biohellenika.gr ) stem cell isolation expansion accord strict clinical grade expansion protocol ( Bakopoulou et al . 2013 ; Bakopoulou et al . preparation ) . Since MSCs isolate expanded vitro Good Laboratory Practice ( GLP ) -compliant clean room ( Biohellenika facility ) meeting quality guideline set European Union animal derive reagent use throughout experiment autologous transplantation , cell consider safe human clinical cell therapy application . In Biohellenika facility , 40ml venous blood collect subject Group-A shortly biopsy harvest , autologous serum use isolation culture expansion autologous stem cell . In addition , autologous fibrin glue use load BM-MSCs onto commercially available collagen fleece . At day surgical placement implant chairside , graft material ( BM-MSCs enrich fibrin glue ) deliver insulin syringe contain 10x10E6 cells/200μl fibrin gently load onto collagen fleece activate addition CaCl2 . Subsequently , biocomplex suture onto lingual flap use bioresorbable suture ( 5-0 Coated VicrylTM ( polyglactin 910 ) , reverse cut 3/8 circle - 16mm , Ethicon , Johnson &amp; Johnson , New Brunswick , NJ , USA ) thus gently stabilize implant platform head partially cover buccal bone . Handling scaffold do care avoid harm viable cell . In Control Group ( Group-B ) , implant place crestally follow manufacturer 's guideline adjunctive use grafting material . One system implant consistently use throughout study group ( Osseotite , Certain , parallel wall , Biomet 3i , Palm Beach Gardens , USA ) . Post-operative care Post-operative pain control Ibuprofen ( 600mg ) end surgical procedure 12h later pain . Amoxicillin ( 500mg / 8 hour 5 day ) prescribe Groups . All patient instruct use 0.12 % chlorhexidine twice daily avoid brush chew hard treat area two week . During 2-week period , patient follow weekly basis record uneventful healing , patient discontinue rinse chlorhexidine solution resume oral hygiene . Thereafter , subject see three four month implant expose . Subjects assessed baseline ( T0 : surgical implant placement ) T1 ( implant exposure 3-4 month ) . Clinical recording determine single calibrated examiner use manual periodontal probe ( Hu-Friedy XP-23/QW , Hu-Friedy , Chicago , IL , USA ) endo-stop attached measurement digitalise use electronic caliper . A customised metallic caliper measure thickness bone buccal/lingual aspect implant . At T0 T1 , clinical recording ass : 1 . Thickness mucosa top alveolar ridge 2- 4mm apically , buccal lingual aspect ridge . 2 . Width keratinize mucosa buccally lingually implantation site . 3 . Thickness buccal lingual bone 0 , 3- 6mm implant shoulder . 4 . Level buccal lingual marginal bone , relation implant shoulder . Standardised digital radiograph collect T0 T1 linearly determine change ( mm ) height alveolar bone implant shoulder teh alveolar crest use VixWin™ Platinum|Gendex software . Groups divide two subgroup base mucosal thickness surgical site T0 [ thin mucosa ( ≤2.5mm ) Groups-AI/-BI ; thick mucosa ( &gt; 2.5mm ) Groups-AII/-BII ] parameter determine compare basis surgical approach mucosa thickness surgical site . A linear mixed model repeat measure use data analysis determine change dimension peri-implant soft hard tissue , around two stage-implants place either conventionally , combination biocomplex .</detailed_description>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>• systemically healthy volunteer poorly control systemic disease heavy smoking ( &gt; 20cigs/day ) bisphosphonate medication antiinflammatory drug bone metabolic disease disorder compromise wound heal immunosuppressive therapy radiation alcohol intake drug abuse past year significant concurrent illness pregnancy/lactation active periodontal disease compromise oral hygiene ( PI ≥25 % )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>surgical implant placement</keyword>
	<keyword>crestal bone</keyword>
	<keyword>mucosa thickness</keyword>
	<keyword>stem cell</keyword>
	<keyword>fibrin glue</keyword>
	<keyword>collagen fleece</keyword>
</DOC>